patalings and his son hunter s business dealings. earlier today, the house oversight committee issued a subpoena for an fbi documentbr . according to a whistleblower, the document links president biden to a, quote, criminal scheme involving, quote, money for policy decisions when he was vicee wa president . we still don t know what other countries were involved, but sources say it was not china.wht what s als io interesting is thm document is from june 2020. that means months before a presidential election, the fbi may have known of joe biden s potential involvemens joet in his son s business dealings. so did they bury this story?d we and if true, n we now havend the several examples of democrats in the media moving the goalposts to protect joe biden. t to prote so first it was the laptop. wasn t real, then it was . but there s no connection to joe. what will be their excuso e? g s now, a man a has been following this all as highly is a u.s. senator from the state of missouri
. now, i m going to turn ove it os to law enforcementha to share an update and our return to share a few additional remarks later. now, i ll turn it over to apd police darren sherbon. than k you , mayor.er wan want to thantk the members ofes. the press for being here this evening. you have played an an important importa a role today as we kept citizens both in atlanta and cobb countyd informed, asked for their assistance as we soughtanh the apprehension of this verany dangerous perpetrator. and thank you for returning tonight to again updatr toe thoe of our various communities. the mayor spoke today ofsponse a capable, competent and brave response by the first responder networ bfirsk that serves nott only the city, but this region. and i just want the menanta and women of the atlanta policeo department to know those that are in our 911 center are firstr responding officers, tacticalame teams, our investigators. how proud yet again i am vie w of the work that you have donebo today on be
Preclinical Data Demonstrate EDP-235's Superior Target Tissue Distribution and Cell Penetration Compared to Other Protease Inhibitors New Preclinical Pharmacokinetic Data Highlight EDP-323's
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta's